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Very little is known about the experience of people living with Parkinson’s disease (PD) in low- and middleincome countries, such as those in sub-Saharan Africa. The number of specialists in the region is low and
awareness is limited among the population and healthcare professionals. Drawing on ten months of ethnographic
fieldwork in urban and rural Kenya with 55 people living with PD (PwP), 23 family members and 22 healthcare
professionals from public and private clinics, we set out to understand the experience of diagnosis among PwP in
Kenya. The diagnostic journeys of our study participants were typically long, convoluted and confusing. Lack of
relevant information, combined with comorbidities and expectations about ‘normal’ ageing, often conspired to
delay interactions with health services for many. There often followed an extended period of diagnostic un
certainty, misdiagnosis and even ‘undiagnosis’, where a diagnostic decision was reversed. Following diagnosis,
patients continued to lack information about their condition and prognosis, making it difficult for friends, family
members and others to understand what was happening to them. We suggest that awareness of PD and its
symptoms needs to improve among the general population and healthcare professionals. However, diagnosis is
only the first step, and needs to be accompanied by better access to information, affordable treatment and
support.

1. Introduction
Parkinson’s disease (PD) is one of most common neurodegenerative
diseases globally yet is almost entirely absent from “global health”
policy discourse and research, especially in low- and middle-income
countries (LMICs). PD is associated with motor symptoms, including
tremor, muscular rigidity (stiffness), slowness of movement, loss of
spontaneous voluntary movement and balance issues (DeMaagd and
Philip, 2015). Non-motor complications (some of which may present
several years before onset of motor symptoms) include depression,
anxiety, apathy, cognitive dysfunction, pain, sleep disturbances, and
incontinence, among others. PD is a progressive condition, so medica
tion cannot alter the course of the disease. However, symptomatic drug
therapy is effective in improving motor symptoms as well as quality and

length of life.
Several PD prevalence studies have been carried out globally yet, as
Okubadejo et al. (2006) and Dekker et al. (2020) have noted, data on
prevalence in sub-Saharan Africa remains extremely limited. Existing
prevalence estimates range from 7 per 100,000 population in Ethiopia
(Tekle-Haimanot, 1985) to 40 per 100,000 in Tanzania (age-standar
dised to the UK) (Dotchin et al., 2008). These estimates are generally
lower than those in high-income countries (HICs), e.g. a prevalence of
667/100,000 in males over 45-years-old in the USA (Marras et al.,
2018), but a lack of diagnostic capacity in LMICs (as we discuss below)
means that these are almost certainly under-estimates. Moreover, as a
condition associated with later life, the prevalence of PD is set to rise
across SSA and other regions of the world as life expectancy continues to
improve (United Nations, 2019). Dorsey and Bloem (2018) warn of an
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imminent “Parkinson Pandemic”, with the number of people living with
PD globally projected to rise from 6.2 million currently to a conservative
estimate of 12.9 million by 2040.
Sub-Saharan Africa, and other lower-income regions of the world,
are ill-prepared to manage this situation, with diagnostic and treatment
capacity lagging far behind most HICs (Dotchin et al., 2007; Dorsey and
Bloem, 2018). Although prevalence is almost certainly rising, PD re
mains a largely unknown condition across Africa, and people experi
encing symptoms associated with PD often face considerable social
stigma and lack access to biomedical treatment due to misdiagnoses and
financial barriers to healthcare (Mshana et al., 2011; Kaddumukasa
et al., 2015; Mokaya et al., 2017; Walga, 2019).
A lack of specialist neurological services across the continent makes
diagnosis challenging (Dotchin et al., 2007), while PD treatment is often
unavailable or unaffordable (Mokaya et al., 2016; Okubadejo et al.,
2019). Early diagnosis and effective treatment can delay onset of severe
symptoms, thereby increasing both length and quality of life and
reducing the burden of care on family members (Dotchin et al., 2014). In
Tanzania, Mshana et al. (2011) found that barriers to diagnosis and
treatment resulted in PwP experiencing emotional, psychological and
physical difficulties, reducing their, and their caregivers, quality of life.
Understanding the challenges that people with Parkinson’s disease
(PwP), their families and healthcare professionals face in diagnosing and
managing PD in resource-constrained settings is therefore crucial;
however, we currently know very little about how PwP access, and
interact with, healthcare services in LMIC settings or how they negotiate
life with PD.
This paper focuses on the first pre-requisite to managing PD effec
tively: obtaining a timely and reliable diagnosis. We know from earlier
studies (Okubadejo et al., 2006; Dotchin et al., 2007, 2008; Dotchin and
Walker, 2012), that many – probably most – PwP in SSA are not diag
nosed and, if they are, diagnosis is usually delayed. Delayed diagnosis is
not exclusive to LMICs: in some HICs, PwP are reported to delay seeking
care for some time after onset of symptoms (Schrag et al., 2018), and this
may be particularly true for under-served sectors of the population (for
example, African-American and Latino populations; see Dahodwala
et al. (2009)). However, given the lack of specialist services, this is likely
to be a very significant issue in Africa and other lower-income regions.
We report below on a qualitative, ethnographic study on the expe
riences of Parkinson’s disease in Kenya, an East African country with
relatively good levels of healthcare provision compared with other
countries in the region. The specific focus is on understanding how
people negotiate what is typically a long and convoluted diagnostic
process. More generally, this study also contributes to the small but
growing literature on PD and ageing in Africa. Drawing on concepts and
theories derived from studies on other chronic conditions in SSA, we
situate the findings within ideas and expectations around ageing,
“personhood” (Degnen, 2018) and “interdependence” in later life
(McIntosh, 2017); chronic and existential “uncertainty” (Whyte, 2009);
and the role of “biolegitimacy” (Fassin, 2009) in making sense of the
condition. However, as we shall see, PD diverges in some important
ways from some other, ‘higher-profile’ chronic conditions (HIV/AIDS
and diabetes, for example), owing not least to its relative political
invisibility and its inevitably progressive nature.

Wairiuko et al., 2017). During the years 2017–2019, 11.3% of the
working-age Kenyan population (aged 15–64) were actively contrib
uting to a pension scheme (ILO, 2018).
1.2. Epidemiological profile
Kenya has seen significant improvements in life expectancy (66 years
in 2017) since the turn of the century (51 years in 2000) (United Na
tions, 2019), associated with significant reductions in maternal and
child mortality, and action on major infectious diseases (especially
malaria, tuberculosis, HIV) in line with Millennium Development Goal
targets (United Nations, 2008). However, as with many LMICs, an
increasing ageing population coupled with significant ‘lifestyle shifts’
has been associated with a rising prevalence of non-communicable
diseases (NCDs) and, often, multiple co-morbidities, placing significant
new pressures on health services (Bigna and Noubiap, 2019). In 2018,
NCDs accounted for 50% of inpatient admissions in Kenyan public fa
cilities and 40% of hospital deaths (Onyango and Onyango, 2018).
1.3. Healthcare services and associated costs
PD cannot be ‘cured’, but effective management under neurologists
and geriatricians (with specialisation in movement disorders) can slow
progression and improve quality of life. However, clinical capacity in
these areas is very limited across the African continent (Dotchin et al.,
2013; Bower et al., 2014). Kenya is among the better served African
countries in this respect, with numbers increasing in recent years, but it
still has fewer than 20 neurologists, all of whom are located in three
major cities (Fothergill-Misbah et al., 2020a).
Capacity in Kenya is particularly limited in the public sector (WHO,
2019). The main national referral hospital in Nairobi holds Kenya’s only
public neurology clinic, yet it is chronically understaffed (The National
Assembly, 2019); overwhelmed clinics mean that registrars with limited
specialist training often run outpatient clinics with little or no supervi
sion. Outside the capital city, there is no public-sector provision at all for
PD. The private healthcare sector in Kenya is one of the most
highly-developed in Africa (Barnes et al., 2010) yet, as noted above,
treatment is only available in the three major cities. Even for those living
within reach of a hospital offering appropriate treatment, user consul
tation costs can be prohibitive. As of 2019, public clinic fees were $6
while private fees could reach $300 – completely unaffordable for 90%
of Kenyans (Prince, 2018). Mokaya et al. (2016) determined that, based
on a monthly minimum wage in Kenya of 11,222Ksh ($100), individuals
have 7% of their net salary (or $9) left for healthcare costs every month
after basic living expenses. However, with the informal sector ac
counting for more than 80% of Kenya’s workforce (Okungu and McIn
tyre, 2019), most do not receive minimum wage.
This situation is compounded by low coverage of health insurance in
Kenya (19% of the population) (Barasa et al., 2018), with flat-rate
contributions and default penalties deterring informal workers from
enrolling (Barasa et al., 2017). Consequently, out-of-pocket payments
for healthcare drove 1.1 million individuals into poverty in 2018, with
older people, those affected by chronic disease and people regularly
accessing outpatient services disproportionately affected (Salari et al.,
2019).
Against this background, we sought to understand how PwP in Kenya
go about trying to obtain a diagnosis and what challenges they
encounter along the way.

1.1. Research setting and background
This study was conducted across multiple sites in Kenya, a lowermiddle-income country situated on Africa’s east coast. As of 2018,
34.4% of Kenyans were living in extreme poverty (World Bank, 2019).
Although poverty rates are higher in rural Kenya (40%) compared to
urban areas (29%) (Diwakar and Shepherd, 2018), 70% of residents in
the capital city, Nairobi, live in slums and informal settlements (APHRC,
2014). Older people living in slums are becoming increasingly vulner
able because of weakening support networks, ill health, poor access to
health facilities and lack of pension support (Wilunda et al., 2015;

2. Methods
The data presented here come from a larger ethnographic study
exploring the lived experience of PwP, and their families, in Kenya. The
lead author conducted ten months of ethnographic fieldwork in Kenya
(March 2018–December 2018 and May 2019), involving participant
observation, in-depth semi-structured interviews and informal
2
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conversations with PwP, family members and healthcare professionals.
An ethnographic approach enabled a holistic and in-depth understand
ing of how PwP and their families lived with, and managed, PD in a
resource-constrained setting characterised by uncertainty and
improvisation.

present during interviews with family members, allowing them to
discuss their experiences freely. In many cases, a family member was
present with PwP during their interviews. Formal interviews and
informal conversations with healthcare professionals drew on their own
practise, knowledge of PD, experience of caring for PwP, and experience
of private, public and alternative therapeutic landscapes, totalling 14.5
h. All formal interviews were audio-recorded (with consent). Informal
conversations were not audio-recorded as this risked rapport, particu
larly with healthcare professionals who were generally busy during
practice hours. Instead, detailed field notes were handwritten.
Observations (165 h in total) aimed to gain an empathetic under
standing of participants’ emotions, feelings, behaviours, experiences
and social interactions within a culturally specific setting. Thirty-six
hours of observations took place in public neurology clinics, and 12 h
in private neurology clinics. Observations offered insights into groups of
PwP with fewer resources who accessed public care and those who
accessed private Kenyan biomedical services – private neurologists
charged a significantly higher fee. Ethnographic observations detailed
how people manoeuvred the clinic and negotiated challenges, their ac
tions and emotions, the ‘system’ of the clinics, routine of events, con
sultations, people’s interactions with neurologists and registrars, and
interactions between patients, family members, friends and hospital
staff.

2.1. Participants and study sites
The majority of fieldwork was conducted in two major cities, Nairobi
and Mombasa, with shorter periods of study in rural settings (seven days
in rural central Kenya and two days in Western Kenya) to understand
what services outside of neurology were available. Fifty-five PwP were
recruited from: two private neurology clinics (one in Nairobi (N = 9) and
one in Mombasa (N = 16)); one public neurology clinic in Nairobi (N =
12); and a PD support group in Nairobi (N = 18). Of the 55, 39 PwP lived
in urban areas, while 16 lived in rural Kenya and had travelled to Nai
robi or Mombasa for diagnosis and follow-up. The sample is heavily
skewed towards urban residents by necessity: neurology clinics and
support groups are available only in the major cities and are unreachable
for most rural Kenyans. The only rural residents in the sample were
those with sufficient resources and connections to be able to travel to the
city to seek diagnosis and/or care. This is a limitation of the study but
one that is difficult to avoid, since the vast majority of rural Kenyans
with PD, and those with lower social/financial capital, remain undiag
nosed and thus ‘invisible’. For this reason, we avoid generalising about
rural-urban contrasts; essentially, the act of diagnosis, as well as sub
sequent treatment and support, always happened in cities.
At each clinic, the researcher identified PwP through clinic files, with
permission and help from the staff, and invited PwP to participate. At the
support group meetings, the researcher described the project to at
tendees who then approached the researcher if they were interested.
Most were eager to share their experiences, generating rich data.
Healthcare professionals were also approached for interview at hospitals
and clinics; interviews were conducted with three private neurologists,
four neurologists who worked in private and public clinics, one pallia
tive care specialist, two nurses from an urban public hospital, five reg
istrars from an urban public hospital, five doctors from private rural
hospitals and two doctors from public rural hospitals (Table 1).

2.3. Ethics
Ethical approval for the research was obtained from Kenya Medical
Research Institute (KEMRI) and Newcastle University Research Ethics
Committee. All participants provided written informed consent to
participate after reading the study information sheet (in English or
Kiswahili), or having it read to them; verbal consent was obtained for
interviews to be audio recorded, where applicable. Oral consent for
observations at support groups was an on-going process. However,
informing everyone at the public clinic waiting room (typically over 200
people) was impossible and impractical (Murphy and Dingwall, 2001).
Approval was sought from the chief nurse, information office staff,
nurses and neurologists in the public clinic, and receptionists and neu
rologists in private clinics. The researcher took notes on a
password-protected smartphone during clinics, making their presence
less obvious and intrusive. Gorman (2016, p. 224) notes how ethnog
raphers are increasingly using smartphones as note-taking mediums,
where the “everyday-ness of the smartphone” creates opportunities for
participants to feel more comfortable – a smartphone was not used
during one-on-one conversations.

2.2. Data collection
All interviews and observations were conducted by the first author
who speaks English and Kiswahili. Participants were interviewed in
either English or Kiswahili, according to their preference; the majority
chose English. An additional interpreter was present for interviews
conducted in Kiswahili to ensure accuracy of translation into English. All
materials were translated into English prior to analysis, with a sample
back translated, to check for consistency.
Formal interviews and informal conversations with PwP and family
members took a biographical approach, drawing on participant’s
experience of life before diagnosis through to the end of life, where
relevant, lasting 30–135 min. Informal conversations with 55 PwP
totalled 72.5 h. Formal in-depth follow-up interviews with nine PwP
totalled 9.5 h. In-depth semi-structured interviews with 23 family
members and caregivers totalled 21.5 h of material. No PwP were

2.4. Analysis
Member-checking was used throughout fieldwork by returning
analysed data to participants during support group meetings to improve
the accuracy, validity and trustworthiness of common findings (Birt
et al., 2016). Interview and observation data were analysed using Braun
and Clarke’s (2006) six phases of inductive thematic analysis. This
systematic, ‘bottom up’, reflexive approach allowed themes to be
identified from the data, without trying to fit data into pre-existing
categories or analytic preconceptions and maintaining the depth and
individuality of participants’ stories. The majority of data coding and
analysis was carried out by the first author, with 10% of interview
material coded by a second experienced qualitative researcher who was
not involved in the data collection. This independent analysis was done
to ensure reliability of the coding and to check for subjectivity.
The coding and analytical procedures were as follows. While still in
the field, the first author transcribed all interviews and field notes, and
read them carefully to focus data collection (Phase 1). Analysis required
constant reviewing of interview transcripts, fieldnotes and personal re
flections, using triangulation to test the quality of information and ac
curacy of ethnographic material (Fetterman, 2019). After initial notes

Table 1
Profile of study participants.
Participant

Urban

Rural

Total

PwP
Family member
Private healthcare professional
Private & public healthcare professional
Public healthcare professional
Total recruited

39
19
4
4
7
73

16
4
5
0
2
27

55
23
9
4
9
100

3
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and comments were made, Phase 2 entailed data coding and collation of
material. In Phase 3, conceptualised empirical and theoretical codes
were collated into main and sub-themes after iterative reviewing and
refining by the research team (Phase 4). Themes were defined and
named in Phase 5 and detailed analyses written, telling the story of the
data in the final report (Phase 6). Quotations used in this paper are
representative of wider responses. Reflexivity throughout fieldwork
allowed the researcher to reflect on ideas and experiences, ensuring
integrity (Arber, 2006).

Esther, she had “wasted away”. Esther returned with Leah to Nairobi to
see another private neurologist who asked Leah to write her name, five
or six times, observing the micrographia and slanting of the text (key
features of PD). On this basis, he confirmed that Leah did in fact have
Parkinson’s and prescribed medication. However, they received no
further information; as Esther suggested, “Five minutes in his office is too
much” (i.e. the neurologist was unwilling to give them any more time).
During follow-up appointments, she was cursorily examined, given a
prescription and a date for an appointment in six months. Although
Leah’s condition improved after resuming medication, the family felt
they had been left on their own. Esther struggled to reconcile the
opposing diagnoses of various ‘specialists’.
At home, Leah continued to visit her local hospital for hypertension.
The family had learnt to tell all the doctors they encountered about
Leah’s Parkinson’s diagnosis. Esther said she had seen the staff ‘Goo
gling’ the medication Leah was taking. Esther and Pauline began
“educating” the hospital staff about PD from what they had learnt on the
internet but felt there was nowhere to find out more about the condition,
no one to relate to and no awareness about it in Kenya. Pauline said the
staff were grateful for the knowledge. Esther joined a support group for
PD in Nairobi; until then, she thought Leah was the “only Kenyan” with
Parkinson’s.

3. Results
The study included 32 male and 23 female PwP (Table 1) with very
different financial and social resources and living situations. Ages
ranged from 33 to 81 years old (median age 66.5 years). Time since
diagnosis ranged from one month to 18 years, although onset of symp
toms usually began many years before a diagnosis. Altogether, 34 re
spondents attended private neurology clinics in Nairobi (N = 22) and
Mombasa (N = 12), 12 attended the public neurology clinic in Nairobi
and nine did not attend any neurology clinic. For the reasons noted
above, most study participants were living in urban areas; those based in
rural settings had all travelled to cities for diagnosis/treatment and were
thus not representative of rural Kenyans (with PD) in general.
Thematic analysis revealed three main themes in relation to PD
diagnosis, explored in turn below: first, the range of initial symptoms
experienced by PwP and how these sit within expectations around
norms of ageing and associated comorbidities; second, the complexity
and uncertainty surrounding diagnosis and experiences of misdiagnosis;
and third, the importance of information provision and, specifically,
knowing the name of the condition. This section is prefaced with an
ethnographic account of one individual – Leah – whose experiences
serve to illustrate each theme. Pseudonyms are used throughout.

3.2. Recognising symptoms
Leah’s story illustrates how people may (mis-)interpret symptoms
when there is little or no prior awareness or knowledge of PD in Kenya.
Distinguishing backache and “old people problems” from PD is extremely
challenging, particularly when knowledge among healthcare pro
fessionals is so limited, resulting in numerous misdiagnoses, even among
specialists. The symptoms of PD are easy to confuse with those of betterknown conditions, pre-existing comorbidities, or merely expected tra
jectories of ageing.
PwP often recalled their experience before diagnosis with phrases
like: “I started feeling funny” or had “strange feelings” or “my body was not
behaving well”. However, these aches, pains, fatigue, and slowness were
often assumed to be part of ‘normal’ ageing, not requiring particular
medical attention. The symptoms of PD could thus be disguised for
years:

3.1. Leah’s story
Leah was 78-years-old and lived in the house she and her husband
had built many years ago in rural Kenya. One of her daughters, Pauline,
lived nearby; she looked after her parents while also running her own
business. Her other daughter, Esther, lived and worked in Nairobi.
Esther explained that Leah began experiencing symptoms nine years
ago, complaining of backache and other symptoms they assumed were
“old people problems”. Over the years, Leah’s symptoms deteriorated; she
began to lose her voice and her pain worsened.
After six years, Esther brought Leah to Nairobi to have her back pain
assessed and paid for her to see a private orthopaedic doctor who, after
hearing her speak and seeing her walk, suggested that she consult a
neurologist, mentioning the possibility of PD. Esther tried to take Leah to
see a private neurologist but could not get an appointment: “it was like
the work of the receptionist to turn people away”. Instead, they asked a
family friend who happened to be a neurosurgeon. He confirmed that
Leah probably had PD, sent her for an MRI and prescribed PD medica
tion. However, Esther was puzzled by the fact Leah’s memory was still
good and she had no tremor at all.
Back in rural Kenya, Leah visited a heart specialist for hypertension
in a local hospital. Leah told the specialist that she was taking medica
tion for Parkinson’s, which he questioned, noting that she “had no facial
expression like Parkinson’s”: she was able to smile and was not shaking.
Leah’s symptoms were being controlled by her medication, yet he
‘cancelled’ the medicines. After Leah was effectively “un-diagnosed”,
Esther took her to see another private neurologist in Nairobi who
requested an MRI on her back, prescribed painkillers and confirmed the
“un-diagnosis”. Leah went back home, took the painkillers as prescribed
and almost died as her blood pressure dropped drastically. She then
“abandoned” the painkillers and continued taking her hypertension
medication.
Two years later, Leah was unable to walk or speak; according to

“She [PwP] thought it was something normal and didn’t go to the
doctor. She had slow movement, so thought she was just ageing”
(Daughter of 67-year-old PwP)
Comorbidities could further confuse and disguise the symptoms of
PD. Bouts of dizziness and weakness or falls were often attributed to preexisting diagnosed high blood pressure or low blood sugar. Others
attributed their symptoms to other, better-known conditions like
arthritis or stroke, which mirror some symptoms of PD.
It was usually only when the ‘slowness’ and pain began impacting
significantly on PwPs’ daily lives and their ability to carry out basic tasks
(such as eating ugali (maize meal), or working) that family members
began to suspect that something else might be wrong (Mshana et al.
(2011) reported similar findings among PwP in Tanzania). In some
cases, it was non-family members – friends and sometimes even
strangers – who noticed their “strange” symptoms and convinced them
to seek help.
3.3. The uncertainty and complexity of obtaining a PD diagnosis
Recognising the need to seek medical attention was, however, only
the first part of what were almost always long, uncertain and convoluted
journeys to diagnosis, often with several misdiagnoses along the way.
For example, one participant had taken his mother to 16 different pri
vate doctors before she was eventually diagnosed with PD; she had pain,
a tremor and had begun drooling.
4
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“While we were seeing him [doctor], she had a tremor, and I asked
him, ‘What’s that?’ and he said, ‘It’s a signal from the brain’ and
dismissed it … I thought, ‘OK it’s not serious’” (Son of 78-year-old
PwP)

not told the name of their condition, ‘Parkinson’s disease’. Many PwP
described their frustration that PD had been “forgotten” while other
diseases received more attention and publicity.
“It’s a nuisance. It’s a constant problem … Go and talk of cancer or
diabetes, everyone knows what it is. I feel this condition has not been
given the time it deserves … People here don’t understand. People
here don’t know this disease” (Paul, 70-year-old PwP)

This participant described his “relief” when his mother was finally
diagnosed but also his “disappointment” that she had experienced so
many misdiagnoses. Many others spent months, or years, in search of an
accurate diagnosis. As the daughter of one 71-year-old PwP explained,
her family were “fighting an unknown” while misdiagnoses “kept them in
the dark” for several years. Similar cases of misdiagnosis, or lack of
diagnosis, have been described in Ethiopia (Walga, 2019) and Tanzania
(Mshana et al., 2011).
For our study participants in Kenya, obtaining a diagnosis required
not only dogged persistence, but also having sufficient funds for multiple
consultations, scans, examinations and tests, most of which were
available only in private-sector facilities:

Several participants recalled feeling alone, “clueless” and receiving
very little information (in both public and private facilities) during the
diagnostic process. Some were not told that PD was progressive; the
nephew of one PwP explained, “When we are given medicine, we just as
sume it is for curing”. Neurologists also admitted not providing expla
nations about prognosis. Few PwP reported being provided with any
verbal information at diagnosis.
Informational resources for PwP and their families were extremely
limited, and those that existed were only available in English. Conse
quently, some PwP were at a loss in how to understand and explain their
condition, wondering whether it was their “brain getting rotten”, a result
of working too hard, or a punishment from God or Satan. A few reported
‘Googling’ PD but not all had access to the internet. The limited infor
mation received at diagnosis has also been reported in some HICs
(Parkinson’s Disease Society, 2008; Schrag et al., 2018). However, in
Kenya, this was more extreme: nine of the 12 PwP recruited from the
public clinic did not know they had PD, seriously limiting their oppor
tunity to find out about their condition.
Neurologists who participated in the study were asked to reflect on
why so little information was provided with diagnosis. They readily
admitted that, in both private and public clinics, the time spent with
patients was limited and they were under pressure to rush through ap
pointments. In the public clinic, the main priority was “churning out
numbers” as one neurologist put it. Some neurologists were apparently
reluctant to disclose a specific diagnosis because they worried that pa
tients would then ask lots of questions that they had no time to answer.
Neurologists were more inclined to disclose a diagnosis in private
clinics, although additional explanations were still limited. Although
probably more extreme, this situation is not limited to LMICs; in Europe,
Schrag et al. (2018) identified that only 38% of 1775 PwP felt they had
been given enough time to ask questions at diagnosis.
Neurologists also pointed to the challenges of explaining things –
especially in a short time-frame – to patients with lower levels of edu
cation and English proficiency; as a result, they tended to give more
information to those they perceived to be more capable of understanding
it. As reported by Andersen (2004) in Ghanaian hospitals, neurologists
"categorised" patients according to perceived educational level. Some
admitted to becoming “different doctors” when interacting with patients
with (apparently) lower levels of education and/or fewer resources,
offering less information or time for questions. In some cases, neurolo
gists justified these actions by pointing to the longer amount of time
required to take a proper history from patients or family members who
were less able to explain; as one neurologist put it:

“If we didn’t have money, we would not know the problem, because
you go to a district hospital and get referred, ten years down the line
and you’re not seen” (Son of 69-year-old PwP)
Even for those in better financial situations, the mounting costs often
deterred them from pursuing a diagnosis until their symptoms worsened
significantly. This is reminiscent of Prince’s (2018) description, also in
Kenya, of the ‘back and forth’ that children with undiagnosed cancer
experienced between health centres, hospitals and healers, only
receiving a diagnosis after significant disease progression. Some PwP
reported thinking they might die not knowing what was killing them.
“I was almost giving up, because any time you go to the doctor,
whatever you are getting is not helping you … The last time I went to
that doctor, I told her “Daktari (doctor), now I’m going to die”"
(Christine, 55-year-old PwP)
Both patients and neurologists pointed to the limited awareness
among non-specialist doctors as being a significant obstacle to diagnosis
or referral to a specialist. It was acknowledged that doctors were much
more familiar with other conditions that could produce similar symp
toms, such as stroke or epilepsy, which they saw on a regular basis.
Moreover, as Leah’s case demonstrates, not everyone presents with
‘typical’ symptoms straightaway, leading sometimes to PD being ruled
out as a diagnosis, even where there is some level of awareness of the
condition. As a result of misdiagnoses, some PwP had reportedly been
prescribed “unsuitable” treatment, resulting in worsening symptoms
and/or severe medical scares. Others, who had received a PD diagnosis,
remained uncertain and sought out second (and third) opinions from
different specialists, withholding their previous PD diagnosis for fear
that it may be wrong.
In the face of these obstacles, serendipity could play a key route to
diagnosis. For example, Frank (aged 77) had begun shaking but thought
he was “just getting old”. A friend at his church in Mombasa also noticed
Frank’s hand shaking and insisted he see a doctor. Similarly, in Nairobi,
Matthew (aged 62) had a tremor in his hand, his voice had lowered, and
speech had slowed, but he had not thought these changes required
attention. Again, someone at his church directed him to a neurologist. In
one case, a hospital doctor in rural Kenya happened to have some
knowledge of PD and spotted advanced symptoms in a handful of pa
tients who had been admitted for other conditions. In most cases,
though, doctors in under-staffed rural government hospitals, without
specialist training, are unlikely to pick up cases, especially less advanced
ones; most will go unrecognised unless patients or their families have the
wherewithal to reach a major city to see a neurologist.

“It spills over depending on your, well, one your complexity and how
sick you are. So, if you’re stretcher ridden … you’re there with a
relative who has no idea, that’s going to drag out … Just trying to
extract that information will take much longer” (Neurologist B)
(See also Ferguson and Candib (2002); Van den Berg (2016) for other
examples of challenges around (perceived) language proficiency and
doctor-patient communications in Africa.)
Some neurologists also mentioned their reluctance to deliver bad
news as a reason for withholding a definitive diagnosis. A PD diagnosis
was not a “positive one” as one neurologist put it. Initial treatment for PD
typically results in an initial, immediate improvement of symptoms and
it was difficult, said some, to take away people’s hopes of recovering by
labelling them with a progressive disease with no cure:

3.4. Knowledge, information and understanding of PD at diagnosis
Participants reportedly experienced multiple barriers to gaining
knowledge at diagnosis. Most of those attending the public clinic were
5
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“You know it is Parkinson’s but don’t want to put it clearly … It’s not
going to be a curable disease, you’re going to get worse over time and
you may get all these complications … and I think the patient also
doesn’t want to know” (Neurologist A)

4.1. Expectations around ageing
First, the initial step in diagnosis – recognition by the patient and/or
those close to them that there may be ‘something wrong’ – is closely
bound with expectations about the changes in capabilities and bodily
functions associated with ageing. Becoming stooped, slowing down,
being in pain and developing a slight tremor were widely regarded as
being an inevitable and ‘normal’ part of ageing. This is not unique to
Kenya; similar observations were made in the USA, by Solimeo (2009),
who described how early symptoms of PD are often mistaken for
“normal” ageing processes.
Among our study participants, bodily changes were thought to
require attention only when they began to impact seriously on PwPs’
ability to carry out important daily activities and could no longer be
dismissed as “old people problems”. These threats to “personhood”
(Degnen, 2018) were often therefore defining moments. Luborsky
(1994, p. 240) has suggested that socially legitimated, full personhood is
“earned by achieving and maintaining expected social roles and ideals”.
Those expected roles necessarily shift over the course of a lifetime. In
East Africa, McIntosh (2017) and Whyte (2017) have suggested that a
decline in old age is expected and that a relationship of “desired inter
dependence”, with elders being supported by their kin, is the ideal.
However, as PwPs’ conditions deteriorated, they became increasingly
dependent on others and less able to reciprocate in expected ways,
precipitating a move to seek medical opinions/care.
With a growing ageing population in Africa, we urgently need to
understand more about expectations of ageing and associated social and
political contingencies (Powell and Hendricks, 2009). In particular, we
need to understand why many people in SSA may expect to have some
form of disability as they age (Sagner, 2002), and to what extent this is
associated with the limited diagnosis and treatment of many chronic
conditions (including PD).

As a result, they would often use vaguer terms and explanations:
“something neurological”, “the shaking problem”, “the system is low”,
“nerve issue”, and suchlike, to avoid mentioning the name ‘Parkinson’s
disease’. This phenomenon of physicians withholding ‘bad news’ from
patients and their families has been described in relation to cancer care
in Kenya by Mulemi (2008). Similar considerations led some family
members in our study to collude in this practice in order to ‘protect’ the
PwP from despair. However, as with Mulemi (2008) study, most of our
participants with PD wanted to know what their symptoms meant.
Several expressed the relief that came from receiving a diagnosis, which
helped them to make sense of previously inexplicable symptoms and
take some control of the situation, by beginning treatment, searching for
information and perhaps joining a support group – although, of course,
access to these were heavily contingent on social position, connections
and affordability.
The consequences of not receiving a diagnostic label were manifold
and had important consequences for PwP. It did not necessarily prevent
them from receiving appropriate medication, if they could afford it; as
one neurologist explained, it is quicker to write a prescription than to
provide a detailed explanation. However, it did prevent the opportunity
to share a diagnosis with family and friends, learn how to manage PD,
and took away the option of accessing additional services (albeit that
these were scarce and often unaffordable anyway). It also contributed to
ongoing stigma associated with apparently inexplicable (and perhaps
even supernaturally-acquired) symptoms. For example, Magnus (aged
66) had been told by doctors at the government clinic just to “manage”
his unnamed condition. Alone in Nairobi, Magnus felt he could not re
turn to his village where people would assume that he was the target of
witchcraft; as a result, he had not seen his family in years. Similarly,
Nzambi, aged 58, had been attending the government clinic for 17 years
for his “sickness”, and had developed severe dyskinesia. In the absence
of a plausible explanation for these symptoms, Nzambi’s wife had
recently left him, taking their children with her. The same happened to
two other younger male PwPs, whose families abandoned them, fearing
that malevolent supernatural forces were at play.

4.2. Uncertainty and agency
Uncertainty in the diagnostic journey for our study participants was
multifaceted and took on different forms and depths: it was evident from
the onset of symptoms, during initial consultations and even after
diagnosis, when the lack of definitive clinical tests to confirm PD meant
that diagnosis could later be questioned or even reversed. This contrasts
with the “digital certainty” Whyte (2014) talks of regarding HIV testing
in Uganda, as well as the apparent objectivity of “numbers” associated
with diabetes and hypertension.
To some extent, diagnostic uncertainty thus results from character
istics of the disease itself (lack of specificity in symptoms and diagnostic
tests) and of an underdeveloped and often unreliable biomedical health
system. However, uncertainty is also produced whereby information is
(sometimes deliberately) withheld from patients and caregivers,
because of time constraints during consultations, assumptions on the
part of clinicians about patients’ educational and social positions, or a
desire to avoid communicating disheartening news about an incurable
degenerative condition. Uncertainty thus does important work, poten
tially helping to maintain ‘hope’ in the face of a grim prognosis, but also
serving perhaps to undermine the agency of patients to seek care, live
well, gain legitimacy and form sociality around their condition.
While our study participants varied considerably in their reactions to
diagnosis, for the most part, uncertainty and lack of information were
associated with heightened fear rather than hope, echoing findings by
Selman et al. (2009) on the needs of patients with incurable progressive
diseases in Uganda and South Africa. However, the agency conferred by
diagnostic certainty was nonetheless still limited by the lack of available
treatment options for PwP living in Kenya.

4. Discussion
Through the accounts presented above of PwP, their family members
and neurologists, the reasons why so many PwP in Kenya (and probably
other LMICs) go undiagnosed become clear. First, levels of awareness of
PD are extremely low, even among healthcare professionals. As a result,
symptoms are often dismissed as being a ‘normal’ part of ageing or
associated with (diagnosed and undiagnosed) co-morbidities. Second,
even when symptoms are identified as being problematic (usually only
when they have become advanced), a lack of capacity and training in
Kenya means that misdiagnosis (and even ‘un-diagnosis – reversal of a
previous diagnosis) is common. And finally, whether because of time
constraints, unfortunate stereotyping of certain ‘types’ of patients, or a
well-meaning desire to protect patients from ‘bad news’, in many cases,
neurologists fail to communicate the diagnosis to individuals and their
family/caregivers. In a country like Kenya, where treatment for PD is
scarce and expensive, obtaining a diagnosis is no guarantee of appro
priate care. However, without a diagnosis, accessing information, care
and maintaining the support of a family network become almost
impossible.
As well as illuminating the empirical situation on the ground in
Kenya, the data from this study also speak to wider theoretical concerns
emerging from the rise of chronic conditions associated with ageing in
Africa, which we elaborate below.

4.3. Naming and legitimacy
One important consequence of not knowing the name of their
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condition was the social stigma associated with uncanny symptoms that
were not legitimised with a diagnostic label. Naming symptoms as a
diagnosis has been described as crucial in the social construct of disease
(Fleischman, 1999), enabling those affected to be socially “normalised”
(Jutel, 2011) and enjoy a form of “biolegitimacy” (Fassin, 2009, p. 52).
Writing about HIV/AIDS in South Africa, Fassin proposed that acquiring
a diagnostic label opens up possibilities for making claims to treatment
and care through forms of “biological citizenship” or “therapeutic citi
zenship” (Rose and Novas, 2007; Nguyen et al., 2010; Marsland, 2012).
Subsequent work on therapeutic citizenship in sub-Saharan Africa
has also focussed predominantly on HIV/AIDS and access to life-saving
anti-retroviral therapy (ART) which, especially in the early days, was
available largely through trials and non-governmental organisations.
Crucially, access to treatment, which was highly politicised, depended
absolutely not just on getting a diagnosis but on being able to use that
diagnosis to make claims for medication in the context of a highlyfragmented and contingent treatment landscape (Nguyen et al., 2010;
Whyte, 2012). .
By contrast, PD has remained politically and socially invisible in
Kenya and indeed across the African continent. Unlike HIV/AIDS,
receiving a diagnostic label for PD does not offer a clear pathway to
making ‘citizen-like’ claims to treatment for the vast majority of Ken
yans who cannot afford fees for expensive private clinics and medication
and who lack the necessary social connections (what Whyte (2014)
called ‘technical know-who’) to access services (see also Marsland
(2012)). However, it could, in some cases, enable participants to access
(albeit limited) information and support, plan for their future, and have
their suffering legitimised, for themselves and others. Since the end of
fieldwork, a new material benefit has also emerged: PwP in Kenya can
now register with the National Council for Persons with Disabilities,
entitling members to tax exemptions, state allowances and tax-free
disability aids (Republic Of Kenya, 2019), although the take-up and
impact of this initiative has yet to be seen.

trials (Cilia et al., 2018; Fothergill-Misbah et al., 2020b). However,
technological innovation will need to be accompanied by significant,
joined-up healthcare investment and increased prioritising of geriatric
care to achieve tangible results at a larger scale.
Credit author statement
Natasha Fothergill-Misbah: Conceptualization, Formal analysis,
Funding acquisition, Investigation, Methodology, Writing – original
draft preparation. Richard Walker: Conceptualization, Writing – review
& editing, Supervision. Juzar Hooker: Writing – review & editing. Judith
Kwasa: Writing – review & editing. Kate Hampshire: Conceptualization,
Formal analysis, Methodology, Writing – review & editing, Supervision
Ethical approvals
Ethical approval to conduct this study was obtained from Newcastle
University Research Ethics Committee (Application No.: 1293/14933/
2017), Kenya Medical Research Institute (KEMRI) Scientific Ethics Re
view Unit (SERU) (Reference: NON-KEMRI 609), Kenyatta National
Hospital-University of Nairobi (KNH-UoN) Ethics & Research Commit
tee (P451/06/2018) and Aga Khan University Hospital Nairobi Institu
tional Ethics Review Committee (2018/REC-57).
Declaration of competing interest
None.
Acknowledgements
This work was supported by the UKRI, Economic and Social Research
Council (ESRC) Northern Ireland and North East Doctoral Training
Partnership, United Kingdom (grant number ES/J500082/1). The au
thors would like to thank Professor Suzanne Moffatt for her significant
contribution to this research.

5. Conclusion
This research has contributed to the very limited understanding
about the experience of Parkinson’s disease in sub-Saharan Africa,
through exploring PwPs’ diagnostic journeys in Kenya. Participants
acknowledged their symptoms as ‘abnormal’ through a threat to
personhood and desired interdependence, while constantly negotiating
the deep and multifaceted uncertainty surrounding PD, and the limits of
biolegitimacy. PD, in the context of Kenya and likely other low-resource
settings, differs from conditions which have been the object of political
organisation (for example, HIV). Knowing the name ‘Parkinson’s dis
ease’ does not automatically provide access to claims, services, or
treatment; however, giving a name to symptoms and suffering had
important social implications and allowed PwP to justify their illness to
themselves, family, friends, and society. Diagnostic labels can help to
increase the social and political visibility of a condition like PD that
remains largely off-radar in terms of government and donor support.
Improving PD awareness would not only assist with ensuring early
recognition of symptoms, timely diagnosis, and – if available – the
commencement of appropriate treatment; it would also reduce the
substantial costs associated with referrals and misdiagnoses, while
challenging stigmatising perceptions within communities. However,
with the low number of neurologists, largely unaffordable private con
sultations, and overwhelmed public clinics, access to effective treatment
remains very limited for most Kenyans, particularly perhaps for rural
populations without urban networks and the resources required to travel
to the city. In other words, reliable and timely diagnosis is just the
starting point; it is a necessary but not a sufficient condition for effective
treatment. This next step is beyond the scope of the current paper, but
there has been some promising work around developing low-cost PD
treatment in Africa using Mucuna pruriens, a levodopa-containing legu
minous plant that has demonstrated encouraging results in on-going
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